Sars-Cov-2 Mrna (Tozinameran 6M-4Y) Vaccine Dosage
Applies to the following strengths: preservative-free
Usual Pediatric Dose for:
Additional dosage information:
Usual Pediatric Dose for COVID-19
For investigational use only
6 months through 4 years: 0.2 mL IM for 3 doses, with the initial 2 doses administered 3 weeks apart, and then the third dose administered at least 8 weeks after the second dose
Comments:
- This drug is not approved by the FDA to prevent coronavirus disease 2019 (COVID-19) in patients younger than 5 years old. The FDA has issued an Emergency Use Authorization (EUA) for the use of this drug to prevent COVID-19.
- There are no data are available regarding interchangeability of COVID-19 vaccine products; the same vaccine product should be used for all 3 doses.
- For additional information: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs
Use: Active immunization to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2)
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
Patients turning 4 to 5 years during the primary series:
- Option 1: Use a 2-dose primary series with the orange-capped and bordered vaccine (each 0.2 mL dose contains 10 mcg mRNA)
- Option 2: Administer dose 1 with the maroon-capped and bordered vaccine (each 0.2 mL dose contains 3 mcg mRNA). Doses 2 and 3 may be administered with either:
- Maroon-capped vaccine (3 mcg mRNA/0.2 mL) for patients 6 months to 4 years
- Orange-capped vaccine (10 mcg mRNA/0.2 mL) for patients 5 to 11 years
Precautions
CONTRAINDICATIONS:
- Known history of severe allergic reaction (e.g., anaphylaxis) to the active component or any of the ingredients
Safety and efficacy have not been established in patients younger than 6 months; an EUA is in effect for the use of an experimental vaccine to prevent COVID-19 in patients from 6 months to less than 5 years of age; this drug is not recommended for use in younger patients.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- For IM administration only. Do not inject IV, intradermally, or subcutaneously.
Storage requirements:
- Vials prior to dilution and after: The manufacturer product information should be consulted regarding storage and subsequent thawing of frozen vials.
- Vials after dilution: Store between 2C to 25C (35F to 77F); store in carton to protect from light and discard any vaccine remaining in vial after 12 hours.
- Contains no preservative.
Reconstitution/preparation techniques:
- Requires dilution with sterile 0.9% Sodium Chloride Injection, USP, before administration.
- The manufacturer product information should be consulted.
General:
- After dilution, vials contain ten-0.2 mL doses of vaccine.
- Low dead-volume syringes and/or needles can be used to extract 10 doses from a single vial; if standard syringes/needles are used, the volume may not be sufficient to extract 10 doses from the vial.
- Each dose must contain 0.2 mL of vaccine.
- If the vaccine remaining in the vial cannot provide a full 0.2 mL dose, discard the vial; do not pool excess vaccine from multiple vials.
Patient advice:
- Read the US FDA-approved patient labeling (Patient Information and Instructions for Use).
- Patients and their caregivers should report suspected adverse reactions by contacting the Vaccine Adverse Event Reporting System (VAERS): https://vaers.hhs.gov
More about sars-cov-2 mrna (tozinameran 6m-4y) vaccine
See also:
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
ACAM2000
ACAM2000 vaccine may be used to prevent smallpox and mpox disease in people of any age at high risk ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Afluria
Afluria is a vaccine used to prevent infection caused by influenza virus. Learn about side effects ...
Afluria Preservative-Free Pediatric Quadrivalent
Afluria Preservative-Free Pediatric Quadrivalent is used for influenza prophylaxis
Afluria Preservative-Free Quadrivalent
Afluria Preservative-Free Quadrivalent is used for influenza prophylaxis
Afluria Quadrivalent
Afluria Quadrivalent is used for influenza prophylaxis
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.